๐Ÿ‡จ๐Ÿ‡พ Country Profile

Cyprus

Fast-growing pharmaceutical trade with Cyprus

๐Ÿ‡จ๐Ÿ‡พ $5.0M
Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Janโ€“Dec). Eurostat records what Cyprus imports from India. DGCIS records what India exports to Cyprus. Category and product detail from DGCIS.
$5.0M
Scale
India supplies $5.0M in pharmaceutical products to Cyprus, affordable medicine reaching Europe.
68%
Medicine
Primarily medicine ingredients (68%), supplemented by medicines and surgical & hospital supplies.
5.0ร—
Trajectory
Rapid expansion: Cyprus' imports of Indian pharmaceutical products have grown 5.0ร— over the past decade, from $1.0M to $5.0M.
Context
Part of India's pharmaceutical supply network across Europe.
โœฆ
Impact
A pharmaceutical relationship documented by both countries, verified trade data confirming the flow of affordable medicine.
Export Trend Eurostat CY DGCIS India-reported
Beyond Finished Medicines DGCIS CY 2014–2025

Additional pharmaceutical categories from DGCIS, APIs, surgical, herbal, and more

Category Mix, FY 2025–26 DGCIS
Medicine Ingredients $12.8M (68.4%) Medicines $5.6M (29.8%) Surgical & Hospital Supplies $0.33M (1.8%) Traditional & Herbal $0.02M (0.1%)
Top Products, FY 2025–26 DGCIS
Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $15.1M in active pharmaceutical ingredients and bulk drugs to Cyprus in 2025 (India-reported, DGCIS).

Indian Pharma Investment in Cyprus Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Cyprus: $288M across 36 filings (2011-2026).